144 related articles for article (PubMed ID: 12222869)
1. What can SV40-derived vectors do for gene therapy?
Strayer DS; Zern MA; Chowdhury JR
Curr Opin Mol Ther; 2002 Aug; 4(4):313-23. PubMed ID: 12222869
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy using SV40-derived vectors: what does the future hold?
Strayer DS
J Cell Physiol; 1999 Dec; 181(3):375-84. PubMed ID: 10528223
[TBL] [Abstract][Full Text] [Related]
3. SV40-based gene therapy vectors: turning an adversary into a friend.
Strayer DS
Curr Opin Mol Ther; 2000 Oct; 2(5):570-8. PubMed ID: 11249759
[TBL] [Abstract][Full Text] [Related]
4. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
[TBL] [Abstract][Full Text] [Related]
5. Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele E; Strayer DS
Gene Ther; 2007 Jun; 14(12):939-49. PubMed ID: 17443215
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
[TBL] [Abstract][Full Text] [Related]
7. Viral vectors for gene therapy.
Robbins PD; Ghivizzani SC
Pharmacol Ther; 1998 Oct; 80(1):35-47. PubMed ID: 9804053
[TBL] [Abstract][Full Text] [Related]
8. Replication-deficient rSV40 mediate pancreatic gene transfer and long-term inhibition of tumor growth.
Cordelier P; Bienvenu C; Lulka H; Marrache F; Bouisson M; Openheim A; Strayer DS; Vaysse N; Pradayrol L; Buscail L
Cancer Gene Ther; 2007 Jan; 14(1):19-29. PubMed ID: 16990845
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue.
Goldstein H; Pettoello-Mantovani M; Anderson CM; Cordelier P; Pomerantz RJ; Strayer DS
J Infect Dis; 2002 May; 185(10):1425-30. PubMed ID: 11992277
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing the production of recombinant SV40 vectors.
Vera M; Prieto J; Strayer DS; Fortes P
Mol Ther; 2004 Oct; 10(4):780-91. PubMed ID: 15451462
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors.
Arad U; Axelrod J; Ben-nun-Shaul O; Oppenheim A; Galun E
J Hepatol; 2004 Mar; 40(3):520-6. PubMed ID: 15123369
[TBL] [Abstract][Full Text] [Related]
12. Gene delivery to the liver using simian virus 40-derived vectors.
Strayer DS; Zern MA
Semin Liver Dis; 1999; 19(1):71-81. PubMed ID: 10349685
[TBL] [Abstract][Full Text] [Related]
13. Simian virus-40 as a gene therapy vector.
Vera M; Fortes P
DNA Cell Biol; 2004 May; 23(5):271-82. PubMed ID: 15169607
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral vector platform for transduction of constitutive and regulated tricistronic or triple-transcript transgene expression in mammalian cells and microtissues.
Gonzalez-Nicolini V; Sanchez-Bustamante CD; Hartenbach S; Fussenegger M
J Gene Med; 2006 Oct; 8(10):1208-22. PubMed ID: 16960915
[TBL] [Abstract][Full Text] [Related]
15. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
[TBL] [Abstract][Full Text] [Related]
16. [Development of gene therapy for hematopoietic stem cell using viral vectors].
Dong WJ; Zu ZX; Liu DP; Liang CC
Yi Chuan Xue Bao; 2003 Apr; 30(4):382-8. PubMed ID: 12812066
[TBL] [Abstract][Full Text] [Related]
17. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
[TBL] [Abstract][Full Text] [Related]
18. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
19. Replication-defective genomic HSV gene therapy vectors: design, production and CNS applications.
Burton EA; Fink DJ; Glorioso JC
Curr Opin Mol Ther; 2005 Aug; 7(4):326-36. PubMed ID: 16121698
[TBL] [Abstract][Full Text] [Related]
20. Liver transduction with a simian virus 40 vector encoding insulin-like growth factor I reduces hepatic damage and the development of liver cirrhosis.
Vera M; Sobrevals L; Zaratiegui M; Martinez L; Palencia B; RodrÃguez CM; Prieto J; Fortes P
Gene Ther; 2007 Feb; 14(3):203-10. PubMed ID: 17024107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
